Cargando…

Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys

Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease. We characterized wild-type HPIV2 infection in an in vitro model of human airway epithelium (HAE) and found that the virus replicates to high titer, sheds apically, targets ciliated cells, and induces...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaap-Nutt, Anne, Scull, Margaret A., Schmidt, Alexander C., Murphy, Brian R., Pickles, Raymond J.
Formato: Texto
Lenguaje:English
Publicado: Elsevier Ltd. Published by Elsevier Ltd. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844349/
https://www.ncbi.nlm.nih.gov/pubmed/20139039
http://dx.doi.org/10.1016/j.vaccine.2010.01.050
_version_ 1782179290996015104
author Schaap-Nutt, Anne
Scull, Margaret A.
Schmidt, Alexander C.
Murphy, Brian R.
Pickles, Raymond J.
author_facet Schaap-Nutt, Anne
Scull, Margaret A.
Schmidt, Alexander C.
Murphy, Brian R.
Pickles, Raymond J.
author_sort Schaap-Nutt, Anne
collection PubMed
description Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease. We characterized wild-type HPIV2 infection in an in vitro model of human airway epithelium (HAE) and found that the virus replicates to high titer, sheds apically, targets ciliated cells, and induces minimal cytopathology. Replication of an experimental, live attenuated HPIV2 vaccine strain, containing both temperature sensitive (ts) and non-ts attenuating mutations, was restricted >30-fold compared to rHPIV2-WT in HAE at 32 °C and exhibited little productive replication at 37 °C. This restriction paralleled attenuation in the upper and lower respiratory tract of African green monkeys, supporting the HAE model as an appropriate and convenient system for characterizing HPIV2 vaccine candidates.
format Text
id pubmed-2844349
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Elsevier Ltd. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-28443492011-03-24 Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys Schaap-Nutt, Anne Scull, Margaret A. Schmidt, Alexander C. Murphy, Brian R. Pickles, Raymond J. Vaccine Article Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease. We characterized wild-type HPIV2 infection in an in vitro model of human airway epithelium (HAE) and found that the virus replicates to high titer, sheds apically, targets ciliated cells, and induces minimal cytopathology. Replication of an experimental, live attenuated HPIV2 vaccine strain, containing both temperature sensitive (ts) and non-ts attenuating mutations, was restricted >30-fold compared to rHPIV2-WT in HAE at 32 °C and exhibited little productive replication at 37 °C. This restriction paralleled attenuation in the upper and lower respiratory tract of African green monkeys, supporting the HAE model as an appropriate and convenient system for characterizing HPIV2 vaccine candidates. Elsevier Ltd. Published by Elsevier Ltd. 2010-03-24 2010-02-05 /pmc/articles/PMC2844349/ /pubmed/20139039 http://dx.doi.org/10.1016/j.vaccine.2010.01.050 Text en Copyright © 2010 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Schaap-Nutt, Anne
Scull, Margaret A.
Schmidt, Alexander C.
Murphy, Brian R.
Pickles, Raymond J.
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
title Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
title_full Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
title_fullStr Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
title_full_unstemmed Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
title_short Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
title_sort growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in african green monkeys
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844349/
https://www.ncbi.nlm.nih.gov/pubmed/20139039
http://dx.doi.org/10.1016/j.vaccine.2010.01.050
work_keys_str_mv AT schaapnuttanne growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys
AT scullmargareta growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys
AT schmidtalexanderc growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys
AT murphybrianr growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys
AT picklesraymondj growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys